Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer

por Yasuda, Yuichiro, Urata, Yoshiko, Tohnai, Rie, Ito, Shoichi, Kawa, Yoshitaka, Kono, Yuko, Hattori, Yoshihiro, Tsuda, Masahiro, Sakuma, Toshiko, Negoro, Shunichi, Satouchi, Miyako
Publicado 2017

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

por Tachihara, Motoko, Negoro, Shunichi, Inoue, Takako, Tamiya, Motohiro, Akazawa, Yuki, Uenami, Takeshi, Urata, Yoshiko, Hattori, Yoshihiro, Hata, Akito, Katakami, Nobuyuki, Yokota, Soichiro
Publicado 2018

A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer

por Hattori, Yoshihiro, Kono, Yuko, Itoh, Shoichi, Inoue, Takako, Urata, Yoshiko, Kawa, Yoshitaka, Tohnai, Rie, Kumagai, Toru, Nishino, Kazumi, Uozumi, Ryuji, Morita, Satoshi, Negoro, Shunichi, Imamura, Fumio, Satouchi, Miyako
Publicado 2020

Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR)

por Udagawa, Hibiki, Sugiyama, Eri, Harada, Toshiyuki, Atagi, Shinji, Koyama, Ryo, Watanabe, Satoshi, Nakamura, Yukiko, Harada, Daijiro, Hataji, Osamu, Tanaka, Fumihiro, Kida, Hiroshi, Satouchi, Miyako, Maeno, Ken, Inoue, Akira, Yoh, Kiyotaka, Yamane, Yuki, Urata, Yoshiko, Yoshioka, Hiroshige, Yamanaka, Takeharu, Goto, Koichi
Publicado 2021